American Cancer Society The results of this study demonstrate the psychometric validity of the Penn Arthralgia Aging Scale among breast cancer survivors on aromatase inhibitors. This scale captures women's perceptions of aging due to arthralgia and predicts incremental variance in depression, anxiety, and pain interference above and beyond joint pain severity
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer : a clinical outcomes and biomarker assessment / M.E. Cabanillas, M. Schlumberger, B. Jarzab, R.G. Martins, F. Pacini, B. Robinson, J.C. Mccaffrey, M.H. Shah, D.L. Bodenner, D. Topliss, C. Andresen, J.P. O'Brien, M. Ren, Y. Funahashi, R. Allison, R. Elisei, K. Newbold, L.F. Licitra, S.I. Sherman, D.W. Ball. - In: CANCER. - ISSN 1097-0142. - 121:16(2015), pp. 2749-2756.
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer : a clinical outcomes and biomarker assessment
L.F. Licitra;
2015
Abstract
American Cancer Society The results of this study demonstrate the psychometric validity of the Penn Arthralgia Aging Scale among breast cancer survivors on aromatase inhibitors. This scale captures women's perceptions of aging due to arthralgia and predicts incremental variance in depression, anxiety, and pain interference above and beyond joint pain severity
| File | Dimensione | Formato | |
|---|---|---|---|
|
CNCR-121-2749.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
224.07 kB
Formato
Adobe PDF
|
224.07 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
